India’s First Indigenous Inactivated H5N1 (Clade 2.3.2.1a) Vaccine

Union Minister of Agriculture and Farmers Welfare is set to dedicate India’s first indigenous Inactivated H5N1 (Clade 2.3.2.1a) Highly Pathogenic Avian Influenza (HPAI) Vaccine for Chickens to the nation.

|||5 min Mins. to read
India’s First Indigenous Inactivated H5N1 (Clade 2.3.2.1a) Vaccine
Prelims

India’s First Indigenous Inactivated H5N1 (Clade 2.3.2.1a) Vaccine

Source: PIB

Subject: Science and Technology

Context: Union Minister of Agriculture and Farmers Welfare is set to dedicate India’s first indigenous Inactivated H5N1 (Clade 2.3.2.1a) Highly Pathogenic Avian Influenza (HPAI) Vaccine for Chickens to the nation.

India’s First Indigenous Inactivated H5N1
India’s First Indigenous Inactivated H5N1

About India’s First Indigenous Inactivated H5N1 (Clade 2.3.2.1a) Vaccine:

What it is?

  • India’s first domestically developed veterinary vaccine specifically formulated to immunize chickens against the H5N1 Highly Pathogenic Avian Influenza (HPAI) virus belonging to the genetic lineage Clade 2.3.2.1a.

Organisation: Developed by scientists at the ICAR–National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, Madhya Pradesh.

Aim: To protect India’s poultry population against circulating Clade 2.3.2.1a H5N1 strains, prevent mass bird mortality and culling, safeguard poultry farmers’ livelihoods, and curb cross-species viral transmission to mammals and humans.

Key Features of the Vaccine:

  • Inactivated (Killed-Virus) Formulation: Contains non-replicating, chemically inactivated viral particles that stimulate a robust protective immune response in chickens without any risk of causing vaccine-induced infection or viral reversion.
  • Targeted Clade 2.3.2.1a Specificity: Tailored directly to the predominant H5N1 Clade 2.3.2.1a strain circulating across Indian poultry farms, filling a major global and domestic void where no specific commercial vaccine existed.
  • Developed in High-Containment Biosafety Facilities: Engineered and validated within ICAR-NIHSAD’s specialized high-security biosafety laboratories in Bhopal, leveraging indigenous viral isolates collected since India’s first H5N1 detection in 2006.
  • Tailored for Commercial & Backyard Chicken Flocks: Designed specifically for poultry immunization to prevent the near-100% flock mortality typically triggered by HPAI outbreaks.
  • Supports Structured Biosecurity & Disease Control: Complements existing veterinary surveillance and farm biosecurity protocols by shifting India’s strategy from reactive mass culling toward proactive preventive immunization.

Significance:

  • An indigenous vaccine can reduce mass culling, economic losses and trade disruptions from recurring avian influenza outbreaks, safeguarding poultry farmers.
  • Controlling H5N1 at its avian source reduces zoonotic transmission risks, strengthens public health security and promotes Aatmanirbhar Bharat in veterinary biotechnology.

Recent & Most Viewed

Teaching Pariksha app preview

Download Our App

Use the Teaching Pariksha app for personalised quizzes, smart revision nudges and doubt solving.

4.6 ★Play Store Rating
5L+Practice Questions
14+Years Experience
Download on the App StoreGet it on Google Play